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SUMMARY : Expression of c-myc oncogene was immunohistochemically exam-
ined on aortas of chick embryo of 2-week gestational age, 2-week-old normal cock-
erels, 4-month-old normal roosters and 4-month-old cholesterl-fed roosters. Chick 
embryo showed moderate levels of expression of the c-myc oncogene product in the 
entire wall of the aortas. There was no significant expression of c-myc oncogenic 
protein in the thickened intima and the tunica media of the ascending aortic arch 
and its large branches of the cockerels and normal roosters. Cholesterol-fed roosters 
showed marked expression of c-myc oncogenic protein in the lipid-rich thickened 
intimal lesions of the ascending aortic arch and its large branches. These results 
suggest that c-myc oncogene has a role in proliferation and differentiation of aortic 
medial cells as well as development of atherosclerosis in chickens.
       INTRODUCTION 
 Atherosclerosis is a multifactorial disease 
which affects medium-sized arteries and large 
arteries. Recent studies have indicated that 
proliferation of intimal smooth muscle cells is 
one of the key factors in the development of 
atherosclerosis (2,8). Ross et al. (8) suggested 
that chronic cycles and repair are responsible 
for the development of atherosclerosis, and 
that injury is exacerbated by risk factors for 
atherosclerosis such as hypertension, hypercho-
lesterolemia, and cigarettes smoking. On the 
other hand, the monoclonal hypothesis was 
proposed by Benditt et al. (2) that atheroscle-
rotic plaque represents a benign neoplasm 
originated from a virus or chemical-induced 
cells. Penn et al. (5) have found that transfor-
ming gene, which is different from v-Ki-ras, 
N-ras and v-Ha-ras genes, exists in human 
atherosclerotic plaque DNA. Previously, we 
have reported that several oncogene products
are expressed in human coronary atheroscle-
rotic lesions (10) as well as in thyroid malig-
nant tumor (11). These results seem to support 
the idea that interactions between many differ-
ent cellular events, such as localized systems 
of growth factors and transactivation of 
tissue-specific gene regulation operating 
during embryogenesis (6). The purpose of the 
present paper is to document myc oncogene 
expression in the developing chick aorta and 
atherosclerotic lesions of the cholesterol-fed 
chickens. 
  MATERIALS AND METHODS 
 Three chick embryos, 2 weeks of gestational 
age, were fixed in 10 per cent formalin solu-
tion. Serial sections of 4 micrometer-thicknes 
were made to locate the ascending aortic arch 
and its large branches of the chick embryo. 
The ascending aorta and its large branches and 
the heart were also obtained from five 2-week-
old normal cockerels, and three 4-month-old
normal roosters. Five 1-month-old cockerels 
were fed with an atherogenic diet containing 2 
per cent of cholesterol and 10 per cent of corn 
oil for 3 months. Tissues were fixed in 10 per 
cent formalin solution and embedded in 
paraffin. The paraffin sections were cut into 
4-mirometer thickness and stained with 
hematoxylin-eosin, Mallory azan, and elastica 
van Gieson. Immunoperoxidase staining was 
performed on sectioned tissues by the 
peroxidase -antiperoxidase (PAP) method of 
Sternberger et al. (9). Sections were treated 
with 0.3 per cent hydrogen peroxide to block 
endogenous peroxidase. After exposure to non-
immune serum, the sections were reacted with 
either the primary anti-sera or non-immune 
sera, link antibodies, followed by peroxidase-
anti-peroxidase complex for 1 hour at room 
temperature. The sections were washed three 
times with OA M phosphate buffered solution 
(PH 7.5) for 5 minutes after each antibody 
application and were treated with diamino-
bendizine in hydrogen peroxide. The primary 
antibody for myc oncogenic protein (Oncr. Inc. 
Wako ) was used in this study. Serum 
cholesterol was determined by the enzymatic 
method (TC-S 736, Kyowa, Tokyo). 
          RESULTS 
 At the age of 2 weeks' gestation, the ascend-
ing aortas consisted of spindle cells. Myc 
oncogene product was seen scattered in 
numerous nuclei of spindle cells in the tunica 
media (Fig. 1). Serum levels of cholesterol 
ranged from 137 to 193mg/dl in normal 2-
week-old cockarels and 4-month -old roosters. 
In the aortas of 2-week-old cockerels, two 
types of cells including smooth muscle cells 
and fibroblasts were identified in the tunica 
media. Intimal thickening was not significant-
ly seen (Fig. 2). Some medial smooth muscle 
cells showed weak reaction to the anti-bodies 
for myc oncogene product. The ascending 
aortic arch and its large branches of 4-month-
old rooster had medial architecture with 
alternating layer of muscular and non-
muscular lamellae and slight intimal thicken-
ing (Fig. 3). However, no significant amount 
of myc oncoprotein was demonstrated in all
Fig. 1. Note nuclear oncoprotein staining in 
      spindle cells (N) scattered in the entire 
       wall of the aorta from a chick embryo of 
      2 weeks' gestational age (PAP stainX 180).
Fig. 2. Ascending aortic arch without intimal 
       thickening from a 2 weeks old cockerel 
      (Hematoxylin and eosin stain X180).
Fig. 3. Ascending aortic arch with slight in-
      timal thickening (IT) from a 4 months
       old rooster (Hematoxylin and eosin 
      stain X 180).
layers of the ascending aortic arch and its 
large , branches. 
 Serum levels of cholesterol ranged from 655
to 1806 mg/dl in 4-month-old roosters fed with 
cholesterol. Three months of cholesterol feeding 
produced marked cellular intimal thickeking 
with lipid deposition in the ascending aortic 
arch and its large branches (Fig. 4). Myc 
oncoprotein was intensely demonstrated espe-
cially in foam cells of lipid-rich intimal lesions, 
but not in the tunica media of the ascending 
aortic arch and its large branches (Fig. 5).
Fig. 4. Ascending aortic arch with marked in-
      timal thickening (IT) from a cholesterol-
       fed rooster (Elastica van Gieson stain X 
     180).
Fig. 5. Lipid-rich aortic lesions from a cholest-
       erol-fed rooster showing intense reaction 
      (R) for antibody of myc oncoprotein 
      (PAP stain X180).
        DISCUSSION 
 Lachman et al. (4) reported that myc 
oncogene was first identified in retroviruses 
and has a regulatory function in the control of 
cell growth. Studies of c-myc gene expression 
in a variety of cell types and tissues have
suggested that the c-myc gene was rearranged, 
amplified, and overexpressed in a wide variety 
of human cancers (1, 3, 7). 
 Zimmerman et al. (12) examined the expres-
sion of N-myc, L-myc and C-myc in murine 
newborn and adult tissues including brain, 
kidney, adrenal, thymus, spleen, liver, intes-
tine, lung and heart. They also suggested that 
differential expression of several genes may be 
important in normal develpoment and pre-
dicted the types of tumors in which they are 
expressed or activated. 
 The present result demonstrates that myc 
oncoprotein is present in the aorta of chick 
embryo and the lipid-rich intimal lesions of 
the ascending aortic arch and its branches, but 
not in the tunica media of the aorta. It is clear 
that the myc oncogene has an important role 
in normal embryogenesis of the arterial 
system and atherosclerotic process. Further 
quantitaive, DNA, and RNA studies are 
required to elucidate how proto-oncogenes or 
oncogenes are involved in atherogenesis. 
 A part of this work was presented at the 77 
th annual meeting of Japan Pathological 
Society in Hokkaido in 1988. 
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